bmiMD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.1/10
Best for: one flat compounded GLP-1 price at every dose, visit and shipping included, lower on longer plans
Price is where bmiMD scores best in our breakdown.
Semaglutide
Tirzepatide
Price checked on bmiMD's site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
PartnerbmiMD is a partner: we may earn a commission if you sign up through our links. It doesn't affect the score. How we make money
bmiMD is a New York telehealth weight-loss clinic, run by Medccm, Inc., that prescribes compounded semaglutide and tirzepatide. One flat monthly price covers every dose, with the provider visit and free shipping included, and the rate drops the longer the plan you choose. The clinic also offers metformin ER, bupropion/naltrexone, lipotropic MIC+B12 and sermorelin.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
bmiMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $159/mo
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored bmiMD
Each dimension is scored algorithmically from bmiMD'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.7/10At $159/mo, bmiMD runs about 11% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.4/10bmiMD offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.3/10Online intake and platform experience (consult included in the price); 2 platform features disclosed.
Trust & Safety15%
8.4/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.5/10bmiMD treats patients in all 50 states.
Support10%
6.1/10bmiMD provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this bmiMD review
Last checked October 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $159–$249/mo across 4 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with bmiMD
We walked bmiMD's public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Place your order, then complete a quick online medical questionnaire about your health and weight-loss goals.
- 2A board-certified physician conducts a usually same-day telehealth online visit to evaluate your health data.
- 3If the prescription is approved, medication and supplies ship from a US-based licensed partner pharmacy (usually 3-5 business days).
- 4Ongoing membership includes chat access to your physician and customer service for medication management and refills.
- Per-medication plan pricing is shown publicly before intake: compounded semaglutide from $119/mo on a 12-month plan ($159 month to month), compounded tirzepatide from $179/mo ($249 month to month).
- Order is placed before the medical questionnaire, so payment precedes the clinician review.
- Products are marked HSA/FSA eligible and 'Ready to Ship'.
- Medication ships to the door from a state-licensed network pharmacy, usually 3-5 business days.
- The Terms set the cancellation rule (in the patient portal, at least seven days before renewal), and support runs through orders@bmimd.com; no phone number is listed.
GLP-1 medications bmiMD offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides bmiMD offers
Beyond GLP-1s, bmiMD also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
Plan list: 12 Month $119/month, 6 month $129/month, 3 Month $149/month, 1 month $159/month. Same price at every dose; provider visit and free shipping included.
Plan list: 12 Month $179/month, 6 month $189/month, 3 Month $229/month, 1 month $249/month. Same flat-dose model.
Plan list: 12 Month $119/month, 6 month $129/month, 3 Month $149/month, 1 month $159/month, each shown against a struck-through $229/mo.
Plan list: 12 Month $179/month, 6 month $189/month, 3 Month $229/month, 1 month $249/month, each shown against a struck-through $349/mo.
Ready to get started?
Plans and promotions change often, so check bmiMD's current pricing and active discounts before you decide.
What we like
- Same monthly price at every dose, so titrating up never raises the bill
- Provider visit and free shipping included in every plan
- Compounded semaglutide and tirzepatide, plus metformin ER, bupropion/naltrexone and sermorelin
- First order is an authorization hold, released with no charge if you are not approved
- Plan prices are published on the product pages before intake
Watch-outs
- Cheapest advertised rates require a 12-month plan; month-to-month is $159 for semaglutide and $249 for tirzepatide
- The compounding pharmacy is not named
- Plan payments are non-refundable once your first order reaches the pharmacy
- You must cancel in the portal at least seven days before renewal; an email request alone doesn't cancel
- BBB rates it F, listing 44 complaints over three years, six of them unanswered
- No brand-name Wegovy or Zepbound, and no support phone number listed
bmiMD: a low flat rate that rewards commitment, not loyalty to a dose
bmiMD is a high-volume telehealth weight-loss clinic that connects patients to licensed clinicians in all 50 states and says it has served more than 80,000 members. Its whole pitch is simple, and for most people it holds up: you pay one flat monthly price for compounded GLP-1 medication, and that price does not climb as your dose goes up. If you have shopped around, you know how unusual that is. Plenty of providers start you cheap and then raise the bill every time your dose increases. bmiMD doesn't, and that predictability is the main reason to consider it.
bmiMD is a strong pick for someone who wants mainstream, no-drama access to semaglutide or tirzepatide at a price that stays put. It is not the right fit if you want brand-name Wegovy or Zepbound, a named pharmacy you can vet, or the freedom to leave after one month without paying more. If a named pharmacy is the sticking point, SnagRx lists its four partner pharmacies on its site.
How the pricing works: by plan length, not by dose
People often misread this part. bmiMD's price is flat across every dose, but it varies by how long a plan you commit to up front. For compounded semaglutide, the 1-month plan is $159 a month, and the price steps down as the plan gets longer, reaching the low one-hundreds on a 12-month plan. Compounded tirzepatide starts higher, in the high one-hundreds at its best rate and rising for shorter commitments. In plain terms: the longer you prepay, the cheaper each month gets, and your dose increases never change the number.
Every plan bundles in the things that are easy to forget to budget for: the provider visit and free shipping on every subscription order are included, not billed on the side. Compared with the category median of about $179 a month, bmiMD's semaglutide entry rate is low. Tirzepatide is pricier, as it is almost everywhere, but still competitive.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.
The trade-off behind the low number
That headline rate assumes you buy the longest plan. If you want to try the service for a single month and walk away, you'll pay the top of the range, not the bottom. There's nothing shady about that (it's the same prepay-and-save model gyms and meal kits use), but go in knowing the cheapest figure is a 12-month figure, not a try-it-out figure.
The medications and how they're dispensed
bmiMD prescribes compounded semaglutide and compounded tirzepatide. These use the same active ingredients as Ozempic/Wegovy and Mounjaro/Zepbound, made by a compounding pharmacy rather than the brand manufacturer. There is no brand-name option here, so if your goal is specifically Wegovy or Zepbound, this isn't your provider.
Beyond the two GLP-1s, bmiMD also offers a broader weight-management menu that some patients use alongside or instead of injections: a lipotropic MIC plus B12 option, metformin ER, a bupropion/naltrexone combination, and sermorelin. That makes it more of a full medical weight-loss clinic than a single-drug storefront, which is useful if a clinician decides a GLP-1 isn't right for you. When having mental health care in the same practice is your priority, Wholesome Clinic is an integrative-psychiatry practice in Frisco, Texas that prescribes compounded GLP-1s by telehealth in seven states, though its prices rise with your dose.
What sets bmiMD apart
- Dose-proof pricing. Your monthly cost is locked regardless of titration. As you climb from a starter dose to a full maintenance dose, the bill doesn't follow you up.
- Everything-included plans. The provider visit and shipping are baked in, so the advertised price is close to the price you actually pay.
- Nationwide reach and scale. Coverage in all 50 states and a member base it puts north of 80,000. This is an established operation, not a pop-up.
- A full clinic menu. Lipotropic injections, metformin ER, bupropion/naltrexone, and sermorelin give clinicians more than one lever to pull.
Who should choose it, and who should skip it
Choose bmiMD if you want a low, predictable monthly cost for compounded GLP-1s, you're comfortable committing to a longer plan to get the best rate, and you value an all-in-one clinic that can offer alternatives if a GLP-1 stalls. The flat-per-dose structure is an advantage for anyone who expects to titrate up over time.
Skip it if you need brand-name medication, or if you want to start month-to-month at the lowest price (you can't; short plans cost more). For FDA-approved pens with insurance help, Ro is built around brand-name GLP-1s. Skip it, too, if you're the type who wants the specific compounding pharmacy and its accreditation named before you commit. bmiMD does not publish a named compounding partner, and for some patients that transparency matters.
Trust, safety, and medical oversight
On the reassuring side, there are no FDA warning letters on file for bmiMD, and the company is explicit that prescriptions come from licensed healthcare professionals across all 50 states with a provider visit built into every plan. That's the baseline you want from a telehealth weight-loss service, and bmiMD clears it.
The caveat is transparency. bmiMD hasn't always advertised its pricing openly; the rates live on its semaglutide and tirzepatide product pages rather than up front. It also doesn't disclose a named, accredited compounding pharmacy. None of that is disqualifying, but it does mean you're trusting the brand rather than a supply chain you can check yourself. If pharmacy accreditation is a dealbreaker for you, ask directly before you sign up. There is also Enhance MD, which lists its LegitScript-certified 503A pharmacies and builds Quest lab work into its plans. Worth knowing: it isn't available in 10 states. You can see how we weigh factors like this in our scoring methodology.
Complaints, refunds & cancellation
bmiMD is run by Medccm, Inc. of New York, and its Terms of Service were last updated October 15, 2026. The first order is an authorization hold, not a charge. If a provider doesn't approve you, the hold is released, usually within 7 to 10 business days. Cancel after you submit your intake, though, and a one-time, non-refundable intake processing fee applies. Once your first order goes to the pharmacy, plan payments are non-refundable if you cancel, pause or are unhappy with results. On a multi-month plan you can take the remaining shipments or turn what's left into account credit. If your provider stops treatment for a medical reason, you can choose a credit or a refund minus the shipments already sent.
The renewal deadline is the part that catches people. If renewal holds worry you, GobyMeds doesn't run subscriptions at all, so each order is a single prepaid purchase. bmiMD places a hold for the renewal amount about five days before each renewal date, and you have to pause or cancel by 11:59 p.m. Eastern at least seven days before that date. Do it in the patient portal at portal.bmimd.com, under Account > Subscription, and check that the plan shows as canceled. The refund policy also mentions email, but the Terms say an emailed request doesn't cancel a subscription on its own. Support runs through orders@bmimd.com, which promises a reply within 48 business hours, and the site lists no phone number. On Trustpilot, bmiMD's claimed profile showed 4.3 from 880 reviews as of November 2026, with 13% of them one-star. The BBB gives it an F and lists 44 complaints over three years, six of them unanswered. Disputes go to individual arbitration, and you can opt out by emailing hello@bmimd.com within 30 days of accepting the Terms.
Bottom line
bmiMD does one thing very well: it makes compounded GLP-1 treatment cheap and predictable, with the provider visit and shipping included and no dose-based price creep. Semaglutide at $159 a month on the month-to-month plan, and less on longer plans, is a competitive rate, and tirzepatide is fairly priced for what it is. The two drawbacks are that the best prices require a longer commitment, and that bmiMD asks for more trust on pharmacy transparency than the most open providers do. If those trade-offs sit fine with you, it's one of the better-value mainstream options for getting started.
The Bottom Line
Price is where bmiMD scores best in our breakdown.
Ready to start with bmiMD?
From $159/mo. See current pricing and start your online intake.
bmiMD might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to bmiMD
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Head-to-head
Compare bmiMD vs…
bmiMD scores8.1/10
Side-by-side pricing, medications and scores. Pick a matchup.

bmiMD vs CoreAge Rx
CoreAge Rx scores 8.3/10
bmiMD vs Amazon One Medical
Amazon One Medical scores 8.5/10

bmiMD vs Vytora Health
Vytora Health scores 8.4/10

bmiMD vs Collective
Collective scores 8.3/10

bmiMD vs Found
Found scores 8.3/10
bmiMD vs EverSlim
EverSlim scores 8.3/10
All 45 bmiMD comparisons
- bmiMD vs AgelessRx
- bmiMD vs altRX
- bmiMD vs Belle Health
- bmiMD vs Bodybuilding Health+
- bmiMD vs Brightmeds
- bmiMD vs Direct Meds
- bmiMD vs DudeMeds
- bmiMD vs Eden
- bmiMD vs Embody
- bmiMD vs Enhance MD
- bmiMD vs Gala
- bmiMD vs GobyMeds
- bmiMD vs HealthRX
- bmiMD vs HumeCare+
- bmiMD vs Ivim Health
- bmiMD vs Live Vital
- bmiMD vs Lttl
- bmiMD vs Luvo Health
- bmiMD vs MadeMed
- bmiMD vs MangoRx
- bmiMD vs Maximus
- bmiMD vs MEDGm
- bmiMD vs MEDVi
- bmiMD vs Midi Health
- bmiMD vs NewSelf
- bmiMD vs Oak
- bmiMD vs PlexusDx
- bmiMD vs Ro
- bmiMD vs RxSpan MD
- bmiMD vs Sesame Care
- bmiMD vs ShedRx
- bmiMD vs SkinnyRx
- bmiMD vs SnagRx
- bmiMD vs Sprout Health
- bmiMD vs Strut Health
- bmiMD vs TMates
- bmiMD vs TrimRx
- bmiMD vs Wellorithm
- bmiMD vs YourEra
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this bmiMD review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See bmiMD's current pricing
Plans from $159/mo. Start the online intake to check eligibility and today's price.